Lausanne, May 21th, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of advanced bioinformatics solutions, announced today a partnership with Molecular Vision Laboratory (MVL), a CAP and CLIA-certified medical diagnostic laboratory based in Oregon, USA, providing comprehensive genetic NGS-based testing for inherited retinal dystrophies.
New York and Lausanne, Switzerland - January 10, 2019 - Saphetor SA, the creator of VarSome, announced today a partnership with the Englander Institute for Precision Medicine at Weill Cornell Medicine, the creator of Precision Medicine Knowledgebase (PMKB), a curated resource for the clinical interpretation of cancer variants . PMKB is now a fundamental component of VarSome’s portfolio of over 30 integrated and cross-referenced public data resources as well as VarSome’s implementation of the American College of Medical Genetics guidelines.
Lausanne, Switzerland - November 20, 2018 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a partnership with HPST, s.r.o., an authorized distributor of Agilent Technologies for the Czech Republic. Saphetor’s clinically-certified platform for fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels extends HPST portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.
Saphetor has teamed up with DNAnexus, a leading global genomic cloud services provider in sharing and management of genomic data and tools to accelerate genomics, to build a sample-in, report-out genomic analysis solution. The DNAnexus cloud-based platform is optimized to address the challenges of security, scalability, and collaboration, for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab. Saphetor’s technology is now available on the DNAnexus cloud-based platform.
LAUSANNE, Switzerland – May 25th 2017 – Saphetor, SA, a Swiss precision medicine company dedicated to advancing personalized diagnostics based on next-generation DNA sequencing, announced today a research partnership with the Exome Consortium of University College London (UCL), led by Dr. Vincent Plagnol.